Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China
· Delayed Price · Currency is CNY 9.18
+0.12 (1.32%)
Mar 10, 2026, 11:29 AM CST
SHA:688098 Revenue
In the year 2025, Shanghai Shen Lian Biomedical had annual revenue of 288.27M CNY, down -4.99%. Shanghai Shen Lian Biomedical had revenue of 50.57M in the quarter ending December 31, 2025, a decrease of -8.24%.
Revenue
288.27M
Revenue Growth
-4.99%
P/S Ratio
12.91
Revenue / Employee
737.25K
Employees
374
Market Cap
3.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 288.27M | -15.15M | -4.99% |
| Dec 31, 2024 | 303.41M | 1.93M | 0.64% |
| Dec 31, 2023 | 301.49M | -27.11M | -8.25% |
| Dec 31, 2022 | 328.59M | -29.83M | -8.32% |
| Dec 31, 2021 | 358.43M | 20.70M | 6.13% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Bioeasy Biotechnology | 251.83M |
| Boji Medical Technology | 770.19M |
| Qingdao Vland Biotech INC. | 1.39B |
| Yantai Zhenghai Biotechnology | 347.60M |
| Baolingbao Biology | 2.69B |
| Zhejiang Wecome Pharmaceutical Company | 131.67M |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |